---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "\"As each patient's cancer is unique, we have developed a therapy that turns their solid tumor's genetic signature into a ... Our partnership with NEC ensures that TG4050 is benefitting from its world-leading expertise in artificial intelligence and its unique algorithm that is used to select up to 30 patient-specific antigens that allow this ..."
publishedDateTime: 2020-01-06T23:00:00Z
sourceUrl: https://www.benzinga.com/pressreleases/20/01/b15081336/transgene-and-nec-start-two-clinical-trials-with-tg4050-an-ai-powered-cancer-vaccine-for-ovarian-a
ampUrl: https://amp.benzinga.com/amp/content/15081336
cdnAmpUrl: https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/15081336
type: article
quality: 14
heat: 14
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI
  - AI in Healthcare

secured: "8nqKD0dysOYiQwp1oUzBcQXucya5baIp5OxiSocg778vmNOq76IMHaBTntUUaBCNjbWnPL9iDfYy8shTfHGCmwGhjXJ+/tleB6UqeKI3DNc12q/MhvblEdWIJyrQ0YTkDfXpYrECTz4FnRz/q+k1jHybr3DSbmcqpJkRh99SamvOFyBDe5ehVRUNMl6uxtB9fidbV7DSimSOcNQNilhCZRo0xblEvGufoDvxo6rfN4h3SOZJG7ZvuNZwdZE0+7AFx4+cuJ1eGrxfe86CWRmT4Q==;pXS1avKASrCGqRf1aUxZAw=="
---

